Contact
Please use this form to send email to PR contact of this press release:
ImmunoGen Presents Additional Analyses Evaluating Mirvetuximab Soravtansine in Ovarian Cancer at ESMO
TO:
Please use this form to send email to PR contact of this press release:
ImmunoGen Presents Additional Analyses Evaluating Mirvetuximab Soravtansine in Ovarian Cancer at ESMO
TO: